West Virginia Attorney General Patrick Morrisey unilaterally sued the U.S. Drug Enforcement Administration in December 2017, which will lead to sweeping reforms and significantly fewer opioid prescriptions in our country.
The lawsuit sought greater transparency and broader input in the process DEA uses to establish the limit on how many opioid pills can be manufactured each year.
Thursday yielded the first glimpse of change – a directive from U.S. Attorney General Jeff Sessions to the DEA just hours before a key deadline in Attorney General Morrisey’s lawsuit.
“The era of unlimited supply must end,” Attorney General Morrisey said. “We are losing too many neighbors, too many friends, too many sons and too many daughters to senseless death.
“The DEA’s quota system is fundamentally broken. For far too long, it served the industry’s wants, instead of the patients’ needs, inexcusably neglecting evidence of diversion to rely on a formula that continues to kill hundreds each day. This must stop.”
Attorney General Morrisey moved to suspend his lawsuit Thursday upon receiving the federal directive, in which U.S. Attorney General Sessions ordered DEA to evaluate and consider potential changes to the regulation.
Attorney General Morrisey is hopeful the directive will take the necessary steps to account for diversion, increase input from specific stakeholders and establish mandatory hearings in setting the quota for specific drugs.
He believes the new process will require DEA to formally seek input from the U.S. Department of Health and Human Services, Food and Drug Administration, Centers for Disease Control and every state in the nation.
Read the lawsuit at http://bit.ly/2HROsdr, as well as U.S. Attorney General Sessions’ directive at http://bit.ly/2GXfRcH and Attorney General Morrisey’s motion to hold the case in abeyance at http://bit.ly/2FJ3G3L.